رجوع
20
50
نطاق اليوم
KWD 0.23
KWD 0.23
نطاق 52 أسبوعًا
KWD 0.23
KWD 0.23
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 0.23
/
KWD 0.23
الإغلاق السابق
KWD 0.23
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 4.6 | 0.3 |
| P/B | 0.3 | 2.9 |
| ROE % | 6.5 | 3.7 |
| Net Margin % | 17.1 | 3.8 |
| Rev Growth 5Y % | 19.4 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 0.108
KWD 0.108 – KWD 0.108
|
1.7 B | 1 |
| FY2026 |
KWD 0.079
KWD 0.079 – KWD 0.079
|
1.5 B | 1 |
النقاط الرئيسية
Revenue grew 19.36% annually over 5 years — strong growth
Earnings declined -15.52% over the past year
Net margin of 17.06% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 38.46M in free cash flow
P/E of 4.62 — trading at a low valuation
النمو
Revenue Growth (5Y)
19.36%
Revenue (1Y)2.88%
Earnings (1Y)-15.52%
FCF Growth (3Y)-14.69%
الجودة
Return on Equity
6.48%
ROIC3.99%
Net Margin17.06%
Op. Margin14.29%
الأمان
Debt / Equity
0.00
Current Ratio2.86
Interest Coverage98.59
التقييم
P/E Ratio
4.62
P/B Ratio0.29
EV/EBITDA1.97
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.88% | Revenue Growth (3Y) | 9.00% |
| Earnings Growth (1Y) | -15.52% | Earnings Growth (3Y) | -17.32% |
| Revenue Growth (5Y) | 19.36% | Earnings Growth (5Y) | 0.72% |
| Profitability | |||
| Revenue (TTM) | 1.30B | Net Income (TTM) | 222.39M |
| ROE | 6.48% | ROA | 4.54% |
| Gross Margin | 75.28% | Operating Margin | 14.29% |
| Net Margin | 17.06% | Free Cash Flow (TTM) | 38.46M |
| ROIC | 3.99% | FCF Growth (3Y) | -14.69% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.86 |
| Interest Coverage | 98.59 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 4.62 | P/B Ratio | 0.29 |
| P/S Ratio | 0.79 | PEG Ratio | -2.48 |
| EV/EBITDA | 1.97 | Dividend Yield | 0.00% |
| Market Cap | 1.03B | Enterprise Value | 366.80M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.30B | 1.27B | 1.10B | 925.33M | 642.30M |
| Net Income | 222.39M | 263.24M | 325.34M | 292.47M | 216.09M |
| EPS (Diluted) | 0.05 | 0.06 | 0.07 | 0.06 | 0.05 |
| Gross Profit | 981.44M | 995.64M | 873.93M | 747.53M | 513.15M |
| Operating Income | 186.34M | 383.28M | 375.93M | 328.74M | 264.49M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 4.90B | 4.70B | 3.69B | 3.18B | 2.95B |
| Total Liabilities | 1.42B | 1.37B | 769.05M | 653.61M | 596.06M |
| Shareholders' Equity | 3.49B | 3.37B | 2.90B | 2.50B | 2.34B |
| Total Debt | 4.98M | 9.30M | 9.67M | 15.67M | 185.98M |
| Cash & Equivalents | 665.76M | 979.31M | 833.79M | 1.12B | 971.68M |
| Current Assets | 2.33B | 2.23B | 1.40B | 1.84B | 1.54B |
| Current Liabilities | 815.64M | 770.14M | 584.74M | 481.91M | 493.60M |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#730 of 827
#135 of 709
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026